Stifel Financial
BRLI

Stifel Financial’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Stifel Financial’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-15,984
Closed -$443K – 2324
2014
Q1 		$443K Buy
+15,984
New +$418K ﹤0.01% 1493

Other funds holding BRLI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
MRM
Michael R. Murphy $255M AUM 0.87% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Stifel Financial's BRLI Position: Q2 2014 in Review

Stifel Financial sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q2 2014, closing a stake of 15,984 shares — an estimated $443K sold.

Stifel Financial first reported a position in BRLI in Q1 2014 and held it in 1 quarter. The position peaked at $443K in Q1 2014. 168 funds tracked by Wall St. Rank hold BRLI as of Q2 2014.

  • Stifel Financial reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q2 2014 after selling out during the quarter.
  • Stifel Financial sold 15,984 BIO-REFERENCE LABS INC-NEW- shares in Q2 2014, an estimated $443K.
  • Stifel Financial first reported a position in BIO-REFERENCE LABS INC-NEW- in Q1 2014 and held it in 1 quarter.
  • Stifel Financial's BIO-REFERENCE LABS INC-NEW- position peaked at $443K in Q1 2014.
  • 168 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q2 2014.

Based on Stifel Financial's 13F filing for Q2 2014, filed 14 Aug 2014.